Primary Record
finasteride
- In stock
- 6,083 g
- Purity
- 99.7 %
- CAS
- 98319-26-7
Compound Identifiers & Properties
- CAS
- 98319-26-7
- PubChem CID
- 57363
- SMILES
- C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C
- Canonical SMILES
- CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C
Names & Synonyms
- finasteride
- Proscar
- Propecia
- Finastid
- Prostide
- Chibro-Proscar
- Finasterida
- Finpecia
- 98319-26-7
- Finasteridum
- Propeshia
- Chibro Proscar
- Prosteride
- Eucoprost
- Andozac
- MK-906
- Finastride
- Urprosan
- Aindeem
- Fistide
- Finara
- Finast
- Fincar
- Prodel
- Finax
- Finasteride CRS
- Propecia (TN)
- Pro-Cure
- Proscar (TN)
- Finasteridum [INN-Latin]
- Finasterid (TN)
- Finasterida [INN-Spanish]
- Prosteride (TN)
- Alternova (TN)
- Finpecia (TN)
- Appecia (TN)
- Finalo (TN)
- Finara (TN)
- Finast (TN)
- Fincar (TN)
- Gefina (TN)
- Finax (TN)
- MK 906
- Finasteride (Proscar)
- Finasteride (Standard)
- CHEMBL710
- RefChem:57216
- DTXSID3020625
- Finasterid IVAX (TN)
- AC1L1MUF
- Finasteride (USP/INN)
- FINASTERIDE [MI]
- Finasteride [USAN:INN:BAN]
- Prestwick0_000717
- Prestwick1_000717
- Prestwick2_000717
- Prestwick3_000717
- 57GNO57U7G
- CCRIS 7438
- FINASTERIDE [INN]
- FINASTERIDE [JAN]
- MSD Brand of Finasteride
- UNII-57GNO57U7G
- C23H36N2O2
- MK906
- FINASTERIDE [USAN]
- D08IWD
- DTXCID50625
- Lipha Brand of Finasteride
- FINASTERIDE [VANDF]
- HSDB 6793
- AC1Q5L2C
- SCHEMBL5509
- CHEBI:5062
- DBEPLOCGEIEOCV-WSBQPABSSA-N
- FINASTERIDE [MART.]
- MFCD00869737
- BSPBio_000933
- FINASTERIDE [WHO-DD]
- MLS000759404
- MLS001165768
- MLS001424046
- Finasteride (JAN/USP/INN)
- Merck Brand 1 of Finasteride
- Merck Brand 2 of Finasteride
- NSC-741485
- MK 0906
- MK-0906
- SPBio_002854
- Finasteride [USAN:BAN:INN]
- Proscar, Propecia, Finasteride
- BPBio1_001027
- GTPL6818
- orb1310564
- ENTADFI COMPONENT FINASTERIDE
- Finasteride - Bio-X trade mark
- Finasteride [USAN:USP:INN:BAN]
- NSC-759318
- BRN 4269024
- D11AX10
- FINASTERIDE [EP IMPURITY]
- FINASTERIDE [ORANGE BOOK]
- G04CB01
- YM-152
- BCPP000229
- FINASTERIDE [EP MONOGRAPH]
- FINASTERIDE [USP IMPURITY]
- Finasteride CRS (Y0000090)
- GLXC-07945
- HMS1570O15
- HMS2051F09
- HMS2090G22
- HMS2097O15
- HMS2235L23
- HMS3714O15
- FINASTERIDE [USP MONOGRAPH]
- ACT02599
- CID57363
- EX-A1951
- Frosst Iberica Brand of Finasteride
- KS-1058
- ZINC3782599
- Tox21_110717
- Tox21_201506
- Tox21_302744
- AN-615
- BDBM50334788
- CID:57363
- EBC-07651
- HY-13635R
- Merck Frosst Brand 1 of Finasteride
- Merck Frosst Brand 2 of Finasteride
- MSD Chibropharm Brand of Finasteride
- MSK011113
- NP3378
- NSC741485
- NSC757443
- s1197
- AKOS015894916
- C23-H36-N2-O2
- N-tert-Butyl-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide
- Tox21_110717_1
- ACN-043358
- BCP9000685
- CCG-100937
- CS-1767
- DB01216
- FF23286
- Finasteride, >=98% (HPLC), powder
- LS-7397
- MSK011113-100A
- NC00187
- NSC 741485
- NSC 759318
- NSC-757443
- Cahill May Roberts Brand of Finasteride
- N-tert-Butyl-3-oxo-4-aza-5alpha-androst-1-en-17beta-carboxamide
- L-652,931
- NCGC00016965-01
- NCGC00093560-05
- NCGC00256334-01
- NCGC00259057-01
- AJ-45596
- BC200264
- BF164456
- BR-72879
- CPD000466304
- HY-13635
- SC-12178
- SID:53790828
- SMR000466304
- SY058000
- (5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide
- BCP0726000222
- AB1008360
- CAS-98319-26-7
- J367.472J
- ST2419391
- A5143
- AB00513901
- FT-0626429
- Merck Sharp & Dhome Brand 2 of Finasteride
- Merck Sharp & Dohme Brand 1 of Finasteride
- NS00010893
- (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide
- D00321
- Finasteride Solution in Acetonitrile, 100ug/mL
- J10122
- X-2990
- 17beta-(N-tert-butylcarbamoyl)-4-aza-5 alpha-androst-1-en-3-one
- 32329-EP2272827A1
- 32329-EP2275420A1
- 32329-EP2280012A2
- 32329-EP2281815A1
- 32329-EP2292615A1
- 32329-EP2295055A2
- 32329-EP2295416A2
- 32329-EP2295426A1
- 32329-EP2295427A1
- 32329-EP2298748A2
- 32329-EP2298764A1
- 32329-EP2298765A1
- 32329-EP2298768A1
- 32329-EP2301928A1
- 32329-EP2301933A1
- 32329-EP2305640A2
- 32329-EP2305642A2
- 32329-EP2305671A1
- 32329-EP2311453A1
- 32329-EP2311808A1
- 32329-EP2311825A1
- 32329-EP2311827A1
- 32329-EP2311829A1
- 32329-EP2311840A1
- AB00513901-07
- AB00513901-08
- AB00513901_09
- Finasteride, VETRANAL(TM), analytical standard
- N-(2-Methyl-2-propyl)-3-oxo-4-aza-5-alpha-androst-1-ene-17-beta-carboxamide
- 319F267
- 4-Azaandrost-1-ene-17-carboxamide, N-(1,1-dimethylethyl)-3-oxo-, (5alpha,17beta)-
- A845840
- D018120
- Q424167
- SR-01000759414
- (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(tert-butyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
- (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-tert-butyl-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
- SR-01000759414-4
- SR-01000759414-6
- 17b-(tert-Butylcarbamoyl)-4-aza-5a-androsten-3-one
- BRD-K01095011-001-03-5
- BRD-K01095011-001-15-9
- Z1501475008
- Finasteride, British Pharmacopoeia (BP) Reference Standard
- Finasteride, European Pharmacopoeia (EP) Reference Standard
- (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(1,1-dimethylethyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
- ([1-PHENYL-METH-(E)-YLIDENE]-AMINO)-ACETICACIDETHYLESTER
- (17beta-(N-tert-butylcarbamoyl)-4-aza-5alpha-androst-1-en-3-one
- 17-beta-(N-tert-butylcarbamoyl)-4-aza-5-alpha-androst-1-en-3-one
- Finasteride, United States Pharmacopeia (USP) Reference Standard
- (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(tert-Butyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,1
- (5?,17?)-N-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide
- (5a,17b)-N-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide
- 140375-21-9
- FIT
- N-(1,1-Dimethylethyl)-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide
- N-(2-methyl-2-propyl)-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide
- (5ALPHA,17BETA)-N-(1,1-DIMETHYLETHYL)-3-OXO-4-AZAANDROST-1-ENE-17-CARBOXAMIDE
- 4-azaandrost-1-ene-17-carboxamide, N -(1,1-dimethylethyl)-3-oxo-,(5(alpha),17(beta))-
- 4-Azaandrost-1-ene-17-carboxamide, N-(1,1-dimethylethyl)-3-oxo-, (5.alpha.,17.beta.)-
- 4-azaandrost-1-ene-17-carboxamide, N-(1,1-dimethylethyl)-3-oxo-, (5alpha, 17beta)-
- 4-Azaandrost-1-ene-17-carboxamide,1-dimethylethyl)-3-oxo-, (5.alpha., 17.beta.)-
- Finasteride for peak identification, European Pharmacopoeia (EP) Reference Standard
- Finasteride, 98%, an orally active testosterone 5-alpha-reductase inhibitor - 1G 1g
- Finasteride; 98319-26-7; Proscar; Propecia; Finastid; Prostide; Chibro-Proscar; MK-906;
- (1S,2R,7R,10S,11S,14S,15S)-N-tert-butyl-2,15-dimethyl-5-oxo-6-azatetracyclo(8.7.0.0^(2,7).0^(11,15))heptadec-3-ene-14-carboxamide
- (1S,2R,7R,10S,11S,14S,15S)-N-tert-butyl-2,15-dimethyl-5-oxo-6-azatetracyclo(8.7.0.02,7.011,15)heptadec-3-ene-14-carboxamide
- (1S,2R,7R,10S,11S,14S,15S)-N-tert-butyl-2,15-dimethyl-5-oxo-6-azatetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-3-ene-14-carboxamide
- (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-isobutyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide
- (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-isobutyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide;Finasteride
- (4AR,4BS,6AS,7S,9AS,9BS,11AR)-4A,6A-DIMETHYL-2-OXO-2,4A,4B,5,6,6A,7,8,9,9A,9B,10,11,11A-TETRADECAHYDRO-1H-INDENO[5,4-F]QUINOLINE-7-CARBOXYLIC ACID TERT-BUTYLAMIDE
- (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-tert-butyl-4a,6a-dimethyl-2-oxo-1H,2H,4aH,4bH,5H,6H,6aH,7H,8H,9H,9aH,9bH,10H,11H,11aH-indeno[5,4-f]quinoline-7-carboxamide
- (4aR,4bS,6aS,9aS,9bS,11aR)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide
- (4aR,6aS)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide
- (4aR,6aS,11aR)-4a,6a-Dimethyl-2-oxo-hexadecahydro-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide
- (4aR,6aS,7S)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide
- (4aR,6aS,7S,11aR)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide
- (R)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide
- 166896-74-8
- 1h-indeno[5,4-f]quinolina-7-carboxamida, n-(1,1-dimetiletil)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahidro-4a,6a-dimetil-2-oxo-, (4ar,4bs,6as,7s,9as,9bs,11ar)-
- 1H-Indeno[5,4-f]quinoline-7-carboxamide, N-(1,1-dimethylethyl)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-
- 4a,6a,9a-Trimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid (Finasteride)
- 4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide
- 4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide(Finasteride)
- Finasteride; 1H-Indeno[5,4-f]quinoline-7-carboxamide, N-(1,1-dimethylethyl)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-; 4-Azaandrost-1-ene-17-carboxamide, N-(1,1-dimethylethyl)-3-oxo-, (5alpha,17beta)-; (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(1,1-Dimethylethyl)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-1H-indeno[5,4-f]quinoline-7-carboxamide; Appecia; Chibro-Proscar; Finalo; Finara; Finast; Finasterid Alternova; Finastid; Finax; Fincar; Finpecia; Fistide; Geffina; MK 906; N-(tert-Butyl)-3-oxo-4-aza-5alpha-androst-1-ene-17-carboxamide; Propecia; Proscar; Prosteride; Prostide
- N-tert-Butyl-3-oxo-4-aza-5|A-androst-1-en-17|A-carboxamide; N-(2-Methyl-2-propyl)-3-oxo-4-aza-5|A-androst-1-ene-17|A-carboxamide